Alliance for Pandemic Preparedness

March 27, 2020

Factors associated with prolonged viral shedding and impact of Lopinavir/Ritonavir treatment in patients with SARS-CoV-2 infection.

Category:

Topic:

  • In this retrospective cohort study of 120 COVID-19 patients, risk factors for prolonged SARS-CoV-2 shedding include older age and lack of Lopinavir/Ritonavir treatment. 
  • Earlier administration of Lopinavir/Ritonavir treatment could shorten the duration of viral shedding.

Yan et al. (Mar 27, 2020). Factors associated with prolonged viral shedding and impact of Lopinavir/Ritonavir treatment in patients with SARS-CoV-2 infection. Pre-print downloaded Mar 27 from https://doi.org/10.1101/2020.03.22.20040832